Escalating Mean Arterial Pressure in Severe Traumatic Brain Injury: A Prospective, Observational Study.


Journal

Journal of neurotrauma
ISSN: 1557-9042
Titre abrégé: J Neurotrauma
Pays: United States
ID NLM: 8811626

Informations de publication

Date de publication:
15 Jul 2021
Historique:
pubmed: 8 12 2020
medline: 22 2 2022
entrez: 7 12 2020
Statut: ppublish

Résumé

To investigate cerebral autoregulatory status in patients with severe traumatic brain injury (TBI), guidelines now suggest active manipulation of mean arterial pressure (MAP). There is a paucity of data, however, describing the effect on intracranial pressure (ICP) when MAP is raised. Consecutive patients with TBI requiring ICP monitoring were enrolled from November 2019 to April 2020. The MAP and ICP were recorded continuously, and clinical annotations were made whenever intravenous vasopressors were commenced or adjusted to defend cerebral perfusion pressure (CPP) targets. A significant change in MAP burden was defined as MAP >100min.mm Hg over 15 min. The primary outcome was the change in ICP burden over the same 15-min period. Bedside and clinical parameters were then compared between these groups. Twenty-eight patients were enrolled, providing 212 clinical events, of which 60 were deemed significant. Over the first 15 min, 65% were associated with a net negative ICP burden. A greater reduction in ICP burden was observed with events occurring in patients without a history of hypotension at scene (

Identifiants

pubmed: 33280492
doi: 10.1089/neu.2020.7289
doi:

Substances chimiques

Vasoconstrictor Agents 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1995-2002

Auteurs

Chien Yew Kow (CY)

Neurosurgery Department, Alfred Hospital, Melbourne, Victoria, Australia.
National Trauma Research Institute, Melbourne, Victoria, Australia.

Benjamin Harley (B)

Neurosurgery Department, Alfred Hospital, Melbourne, Victoria, Australia.
National Trauma Research Institute, Melbourne, Victoria, Australia.

Charles Li (C)

Neurosurgery Department, Alfred Hospital, Melbourne, Victoria, Australia.
National Trauma Research Institute, Melbourne, Victoria, Australia.

Phillip Romo (P)

Neurosurgery Department, Alfred Hospital, Melbourne, Victoria, Australia.

Panagiota Gkolia (P)

Neurosurgery Department, Alfred Hospital, Melbourne, Victoria, Australia.

Kuan-Ying Lu (KY)

Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Catherine Bell (C)

Department of Intensive Care and Hyperbaric Medicine, Alfred Hospital, Melbourne, Victoria, Australia.

Rondhir Jithoo (R)

Neurosurgery Department, Alfred Hospital, Melbourne, Victoria, Australia.

Jin Tee (J)

Neurosurgery Department, Alfred Hospital, Melbourne, Victoria, Australia.
National Trauma Research Institute, Melbourne, Victoria, Australia.
Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.

D James Cooper (DJ)

Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Department of Intensive Care and Hyperbaric Medicine, Alfred Hospital, Melbourne, Victoria, Australia.

Jeffrey V Rosenfeld (JV)

Neurosurgery Department, Alfred Hospital, Melbourne, Victoria, Australia.
Department of Surgery, and Monash University, Clayton, Victoria, Australia.

Philip M Lewis (PM)

Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
Department of Electrical and Computer Systems Engineering, Monash University, Clayton, Victoria, Australia.

Andrew Udy (A)

Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Department of Intensive Care and Hyperbaric Medicine, Alfred Hospital, Melbourne, Victoria, Australia.

Martin Hunn (M)

Neurosurgery Department, Alfred Hospital, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH